ArticleDiabetes, obesity & metabolism2026

Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use.

Tina Vilsbøll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.